Background Study Objectives Poster No. B50 Track 2  Family planning affects women’s health and lives, and depends on a variety of socio-demographic and.

Slides:



Advertisements
Similar presentations
What does sexual & reproductive health have to do with clinical trials? Providing contraception & reproductive health care helps.
Advertisements

Referral of participants for HIV follow-up care Africa Centre MDP experiences Presented by: Hlengiwe Ndlovu MDP Clinic coordinator.
Measuring unmet need for dual protection in Kenya: an analysis of community survey and family planning client cohort datasets Church K, Friend du-Preez.
Demand for family planning among postpartum women attending integrated HIV and postnatal services in Swaziland Charlotte Warren, Timothy Abuya, Ian Askew,
Contraception/Pregnancies MTN 020. Why do we care? Participants must come off product during pregnancy and breastfeeding – Studies of dapivirine in pregnant.
HIV infection among young people in northwest Tanzania: the role of biological, behavioural and socio-demographic risk factors : randomised controlled.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
Correlates of polydrug use among injection drug users: The role of socioeconomic stress and quality of life Marrero CA, Robles RR, Reyes JC, Matos TD,
Behavioral Intention and Partner Type on Condom Use Among Men in Drug Treatment Yong S. Song, PhD, University of California, San Francisco Donald Calsyn,
C. Andres Bedoya, PhD Behavioral Medicine Service Department of Psychiatry Massachusetts General Hospital / Harvard Medical School Factors related to high-risk.
1,2 BABALOLA OS, 1,2 BELLO B, 1 NDLOVU N 1 UNIVERSITY OF THE WITWATERSRAND, & 2 CENTRE FOR STATISTICAL ANALYSIS & RESEARCH (CESAR), JOHANNESBURG, SOUTH.
Contraceptive use and uptake Hasinah Asmal, Samantha Govender, Ian Naicker, Dinesh Singh, Gita Ramjee.
Contraceptive discontinuation in urban Honduras Janine Barden-O’Fallon, PhD Ilene Speizer, PhD University of North Carolina at Chapel Hill, USA 29 September.
Roger Shapiro Poloko Kebaabetswe Shahin Lockman Serara Mogwe
The Need for Greater Emphasis on Married or Cohabiting Couples in Southern and East Africa John Cleland.
Risk factors for Incident Trichomonas vaginalis among Women Recruited in RESPECT-2, an HIV Prevention Trial D Helms 1, D Mosure 1, T Peterman 1, C Metcalf.
Midwest AIDS Training & Education Center Health Care Education & Training, Inc. HIV/AIDS Case-Finding In Family Planning Clinics.
Susan Adamchak, Heidi Reynolds, Barbara Janowitz, Thomas Grey, Emily Keyes October 21, 2008 FP and HIV/AIDS Integration: Findings from 5 Countries.
First Hand Perspective of working on a Microbicides Phase111 Trial Misiwe Mzimela: Social Science Coordinator at Africa Centre.
Uptake of antiretrovirals in a cohort of women involved in high risk sexual behaviour in Kampala, Uganda J.Bukenya, M. Kwikiriza, O. Musana, J. Ssensamba,
9th INDEPTH AGM, 27th OCT 2009, PUNE INDIA A community based trial of enhanced family planning outreach in Rakai, Uganda Tom Lutalo 1, Edward Kimera 1.
Frequency and predictors of consistent condom use in HIV/AIDS patients receiving antiretroviral therapy in Western Ethiopia Zewdneh Shewamene Sabe (B.Pharm,
PREVALENCE OF ANAEMIA IN WOMEN AT SCREENING AND FOLLOW-UP IN A MICROBICIDE PHASE III TRIAL Hasinah Asmal, Dinesh Singh, Gita Ramjee HIV Prevention Research.
Effects of an HIV/AIDS peer prevention intervention on sexual and injecting risk behaviors among injecting drug users (IDUs) and their risk partners in.
TEMPLATE DESIGN © Improvements of sexual and reproductive healthcare needs of women with HIV in primary care setting W.
Dealing with bi-directionality in mental health research: The experience of the mental health project of the MRC/UVRI E. Kinyanda 1,2 1 MRC/UVRI Uganda.
Family Planning & Reproductive Health in Guatemala Rebecca Braun MPH Candidate 2006 Bixby Program Intern.
Determinants of condom use among young adults aged years in Africa Centre DSA, KwaZulu Natal, South Africa, 2005 Natsayi Z Chimbindi - Agincourt.
Mixed methods in medical research Robert Pool Centre for International Health, Hospital Clinic, University of Barcelona London School of Hygiene & Tropical.
Effectiveness: Overview of Current Approaches and Emerging Trial Designs Doug Taylor, PhD Director of Biostatistics Family Health International.
ANC surveillance research Yusufu Kumogola, Emma Slaymaker, Raphael Isingo, Julius Mngara, Basia Zaba, John Changalucha and Mark Urassa TAZAMA / NACP seminar,
Sterilisation uptake in the Dominican Republic: are women begging for it? Tiziana Leone Department of Social Policy.
When Will Women Have Choices? Sharon Hillier University of Pittsburgh School and Medicine Microbicide Trials Network IAS, Washington DC, July 26, 2012.
EVALUATING A HIV PREVENTION PROGRAM WITH TRANSGENDER WOMEN IN LAOS USING COARSENED EXACT MATCHING (CEM) Saysana Phanalasy Amy Gregowski Gary Mundy Phousiay.
Overview of Microbicide Trials Issues and Challenges.
EFFICACY OF A STAGE-BASED BEHAVIORAL INTERVENTION TO PROMOTE STI SCREENING IN YOUNG WOMEN: A RANDOMIZED CONTROLLED TRIAL Chacko MR, Wiemann CM, Kozinetz.
Male Method Choice in Bangladesh: Does It Matter Who Makes The Decision? Mohammad Amirul Islam Sabu S. Padmadas Peter W.F. Smith Division of Social Statistics.
Contraceptive Options for Women and Couples with HIV.
Unplanned pregnancy in the 2011 Botswana Antenatal Clinic Sentinel Surveillance A.C. Voetsch, M.G. Anderson, E. Machakaire, S. Bodika, W. Jimbo, B.P. Yadav,
Preparing for Data Analysis and Interpreting Data CEI Implementing the Reproductive Health Assessment Toolkit for Conflict-Affected Women November.
Predicting Pregnancy Risk among Women Attending an STD Clinic Judith Shlay MD, MSPH Denver Public Health September 21, 2008 CityMatCH Conference.
Consistency in reporting contraception between spouses in Bangladesh: evidence from recent demographic and health survey Mohammad Amirul Islam Sabu S.
Advances in Task Sharing: Findings from Uganda & Sierra Leone Julia Byington Programme Advisor, Marie Stopes International.
Contraception/Pregnancies. Why do we care? Participants must come off product during pregnancy and breastfeeding Time off product results in dilution.
Microbicides The Population Council Experience and Future Directions Don E. Waldron Medical Director Don E. Waldron Medical Director.
Prevalence and risk factors for self-reported sexually transmitted infections among adults in the Diepsloot informal settlement, Johannesburg, South Africa.
AN INTERNATIONAL MULTI-CENTRE, RANDOMISED, DOUBLE- BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF 0.5% AND 2% PRO 2000 GELS FOR.
Measuring Anal Intercourse in Vaginal Microbicide Studies/Trials
International Partnership for Microbicides Approach to HIV Treatment and Care in Future IPM Microbicide Trials Pam Norick, Chief of External Relations.
Looking Ahead to MTN-017 Ross D. Cranston MD, FRCP Microbicide Trials Network IRMA.
1 Determinants of women's autonomy over sexual behaviors within marital relationships in contemporary Vietnam Hongyun Fu, MA Mai Do, MD, DrPH Lung Duy.
Acceptability Survey of HPV Vaccine Among Female Sex Workers in Lima, Peru Brandon Brown 1, Cesar Carcamo 2, Maria Valderrama 2, Magaly Blas 2, and Neal.
HIV Prevalence and Incidence Estimates Among Women with High Risk Indicators in Addis Ababa, Ethiopia Asfawesen G-Yohanes 1, Stephanie Combes 2, Abraham.
Clare Meernik, MPH 1 ; Anna McCullough, MSW, MSPH, CTTS 1 ; Leah Ranney, PhD 1 ; Barbara Walsh 2 ; Adam O. Goldstein, MD, MPH 1 Predictors of Quit for.
Adesina OA*, Awolude O, Oladokun A, Roberts A, Adewole IF, Department of Obstetrics & Gynaecology, College of Medicine, University of Ibadan. *Corresponding.
Determinants of Family Planning uptake among Female Sex Workers Enrolled in a HIV incidence study in Eldoret Kenya. Authors: J. Kipyego, E. Kaguiri, G.
Risk perception of HIV infection in South Africa: A Nationally Representative Survey Authors: Patience Gamuchirai Manjengwa-Hungwe, K Mangold, M Pule,
Impact of level of researcher support on coital diary results and acceptability among women at high risk of HIV in the Microbicides Development Programme.
Associations Between Recent Gender- Based Violence and Pregnancy, Sexually Transmitted Infections, Condom Use Practices, and Negotiation of Sexual Practices.
Demographic and Behavioral Differences between Latino and non-Latino Patients Attending Baltimore City STD Clinics, Renee M. Gindi 1, Kathleen.
Seeking HIV-testing Only: Missed Opportunity for HIV Prevention?
J. Mossong1, N. Majéry2, C. Mardaga3 , M. Muller4, F. Schneider1
Primary Investigator: Prof. P Reddy Project Director: Ms S James
How informed is consent
On behalf of The MTN-020/ASPIRE Study Team
MULTIPURPOSE PREVENTION TECHNOLOGY (MPT) PRODUCT PIPELINE & THEIR POTENTIAL ACCEPTABILITY AMONG ADOLESCENT GIRLS & YOUNG WOMEN Barbara Friedland, Population.
A study of high risk African American women, 15 to 21 years of age
Contraceptive Method Choice Among Married Women in West Java Province, Indonesia By. Rina Gustiana
The Relationship between Recent Alcohol Use and Sexual Behaviors/STDs: Gender Differences among STD Clinic Patients Heidi E. Hutton PhD, Mary E. McCaul.
VACS Scientific Meeting Houston, TX February 2004
Presentation transcript:

Background Study Objectives Poster No. B50 Track 2  Family planning affects women’s health and lives, and depends on a variety of socio-demographic and cultural factors.  Many South African women either choose not to use family planning or are not able to negotiate FP use with their sexual partners, and are at increased risk for unwanted pregnancies.  The Africa Centre is 1 of 6 sites in the Microbicides Development Programme (MDP) network, conducting a randomized double- blind placebo-controlled phase III clinical trial to evaluate the safety and efficacy of PRO 2000/5 microbicide gel in reducing the risk of vaginally acquired HIV infection. In preparation for the MDP trial, the centre conducted a feasibility study from June 2003 to December 2004 in rural KwaZulu-Natal, South Africa to assess acceptability of study procedures, ability to recruit & retain women, and measure HIV incidence and HIV and STI prevalence. This analysis of feasibility study data has 3 primary aims: (1) Determine prevalence of contraceptive use among women screened for the Microbicide Feasibility Study (MFS); (2) Identify socio-demographic determinants of contraceptive use and method choice; (3) Investigate changes in contraceptive use during the MFS. (1) Current contraceptive use: □ YES: Any modern method (sterilization, IUCD, pills, injectables, barrier methods) □ NO: No method or unreliable method (rhythm/calendar method, withdrawal, herbs, Quinine, other) (2) Primary contraceptive method: □ Invasive methods: Female/male sterilization, IUCD □ Oral methods: Pills □ Injectable methods: Depo-provera, Nur-isterate injection □ Barrier methods: Male/female condom, foam/jelly/ spermicide, diaphragm Women were recruited from family planning and immunization clinics. 888 women were screened and 449 enrolled in the study. Enrolled women were asked to attend follow-up visits 2 weeks after enrollment and then at 3-monthly intervals for a period of up to 12 months. Demographic information was collected at screening visit. Detailed information on use of family planning methods was collected at screening and all follow-up visits. At each study visit women received safer sex counselling, and were offered free family planning services and free condoms. Data analysis was conducted using Stata v.8. Changes in contraceptive use were investigated for 195 enrolled women attending 3, 6 and 9-month follow-up visits. Contraceptive use increased significantly from 56% to 70% and condom use from 15% to 28% over 9 months. Among 861 screened sexually active women with information on all univariate significant predictors, multiple logistic regression was used to evaluate predictors of modern contraceptive use. 466 (54%) women reported using a modern contraceptive method. Methodology Outcome Variables Longitudinal changes in contraceptive use Conclusions Predictors of contraceptive use Table 1: Multivariable predictors of FP use (n=861) Independent variableAdjusted OR* [95% CI]P > χ2 Age 40+ (ref age 15-19)0.38 [ ]0.008 Completed secondary education (ref <5 yrs)1.64 [ ]0.051 Employed (ref unemployed)1.65 [ ]0.003 Married (ref single)1.64 [ ]0.054 Bread expenditure >R20/mo (ref <R20/mo)1.58 [ ]0.020 Number of live births (ref 0 births) [ ] 3.17 [ ] 4.45 [ ] <0.001 Among 466 screened sexually active women using contraception, multiple multinomial logistic regression was used to evaluate predictors of primary contraceptive method choice. Primary contraceptive methods included injectables (30%), condoms (12%), sterilization (6%) and pills (4%). Predictors of contraceptive method choice Family planning methods among women in a vaginal microbicide feasibility study in rural KwaZulu Natal, South Africa. Laura Subramanian 1 ; Nuala McGrath 1,2 ; Hlengiwe Ndlovu 1 ; Mitzy Gafos 1 1 Africa Centre for Health and Population Studies 1 Africa Centre for Health and Population Studies 2 London School of Hygiene and Tropical Medicine (UK)  In a sexually active population in rural KwaZulu-Natal not intending pregnancy, half of women were using modern contraception. The majority were using injectable contraceptives.  Multivariable analyses revealed significantly higher current contraceptive use among women married, multiparous, employed full/part-time, and with secondary education. Women aged 40+ were significantly less likely to be using contraception.  Age, marital status, education level and parity were associated with different contraceptive method choices.  Among 195 women followed longitudinally, contraceptive use, especially condom use, increased significantly over 9 months. This may reflect repeated safer sex counselling.  Family planning clinics and microbicide trials may use information about predictors of contraceptive use to tailor counselling. Table 2: Multivariable predictors of FP method use (n=466) (ref injectables) *adjusted for clinic at recruitment Independent variableAdjusted OR* [95% CI]P > χ2 Condoms (n=107) Pills (n=38) Sterilization (n=55) Age 35+ (ref age 15-24)1.75 [ ]3.57 [ ]13.59 [ ]<0.001 Completed secondary education (ref <5 yrs) 2.77 [ ]2.21 [ ]0.87 [ ]0.085 Married (ref single)0.44 [ ]0.67 [ ]1.77 [ ] live births (ref <2 births) 0.40 [ ]0.93 [ ]9.95 [ ]<0.001 *adjusted for clinic at recruitment